华泰联合证券有限责任公司
Search documents
东鹏饮料(集团)股份有限公司关于使用部分闲置募集资金进行现金管理到期赎回并继续进行现金管理的公告
Shang Hai Zheng Quan Bao· 2026-01-16 21:16
Core Viewpoint - Dongpeng Beverage plans to utilize part of its idle raised funds for cash management, specifically through structured deposits, to enhance the efficiency of fund usage and increase company revenue while ensuring that it does not affect the normal investment plans of the raised funds [2][4][11]. Group 1: Cash Management Overview - The entrusted party for cash management is China Merchants Bank Co., Ltd. [2] - The total amount for cash management is 70 million yuan [2]. - The type of cash management product is structured deposits with a duration of 70 days [2][8]. - The company has authorized the use of up to 100 million yuan for cash management, ensuring that daily operational funding needs and fund safety are prioritized [2][13]. Group 2: Previous Financial Management - The previous structured deposit purchased on October 15, 2025, matured on January 15, 2026, with the principal and earnings fully returned to the raised funds account [4]. - The funds used for this investment are from the company's initial public offering, which raised a total of 1.851 billion yuan, netting 1.732 billion yuan after expenses [5]. Group 3: Risk Control Measures - The company has established a comprehensive internal control system for cash management, including risk assessment and decision-making processes to ensure the safety of funds [6][9]. - The company will select low-risk investment products and monitor market conditions to mitigate potential risks [9][10]. - Independent directors and the sponsor have the authority to supervise the use of raised funds, ensuring compliance with regulations [7][9]. Group 4: Impact on Company - The cash management initiative is not expected to significantly impact the company's main business, financial status, operating results, or cash flow [11]. - The company will report the specifics of the cash management activities in accordance with relevant regulations [10].
2026年科创板首单撤回案例 华泰联合证券保荐项目终止| A股融资快报
Sou Hu Cai Jing· 2026-01-16 13:40
Core Viewpoint - Jiangsu Yadian Technology Co., Ltd. has had its IPO application on the Sci-Tech Innovation Board terminated, marking it as the first company to have its IPO halted in 2026 [1] Group 1: Company Overview - Yadian Technology is a leading supplier of wet cleaning equipment in China, focusing on the research, production, and sales of wet cleaning equipment for silicon-based semiconductors, compound semiconductors, and photovoltaic fields [3] - The company plays a crucial role in the domestic semiconductor cleaning equipment localization process, ranking second among domestic brands in market share for slot-type wet cleaning equipment in 2024 according to third-party reports [3] Group 2: Financial Performance - The company has shown rapid growth in its financial performance, with revenues of 120.73 million yuan, 441.75 million yuan, and 580.41 million yuan from 2022 to 2024, respectively [3] - Net profit attributable to shareholders turned from a loss of 81.01 million yuan in 2022 to a profit of 82.52 million yuan in 2024, indicating a successful turnaround [3] Group 3: IPO Details - Yadian Technology planned to raise 950 million yuan through its IPO, with intended investments in high-end semiconductor equipment industrialization, advanced process semiconductor technology research and development, and working capital [4] - The company faced multiple risks, including high customer concentration, potential underperformance in technology development, large inventory scale, and industry cyclicality [4] Group 4: Regulatory and Market Context - The termination of the IPO reflects the high standards and strict requirements of the Sci-Tech Innovation Board regarding information disclosure quality, technological attributes, and sustainable operational capabilities [5] - The underwriting firm, Huatai United Securities, and its representatives are under scrutiny following the project's termination, which may lead to a reassessment of risk management and project selection in their investment banking operations [5]
华泰联合证券保荐项目终止,成2026年科创板首单撤回案例
Quan Jing Wang· 2026-01-16 07:15
Core Viewpoint - Jiangsu Yadian Technology Co., Ltd. has had its IPO application on the Sci-Tech Innovation Board terminated, marking it as the first company to have its IPO halted in 2026 [3] Group 1: Company Overview - Yadian Technology is a leading supplier of wet cleaning equipment in China, focusing on the research, production, and sales of wet cleaning equipment for silicon-based semiconductors, compound semiconductors, and photovoltaic fields [3] - The company's products are primarily used in critical processes such as cleaning in the front-end wafer manufacturing of the semiconductor industry, playing a vital role in the upstream of the semiconductor supply chain [3] - According to third-party reports, Yadian Technology ranked second among domestic brands in market share for slot-type wet cleaning equipment in 2024 [3] Group 2: Financial Performance - The company has shown rapid growth in its financial performance, with revenues of 120.73 million yuan, 441.75 million yuan, and 580.41 million yuan from 2022 to 2024 [4] - The net profit attributable to shareholders after deducting non-recurring gains and losses transitioned from a loss of 81.01 million yuan in 2022 to a profit of 82.52 million yuan in 2024 [4] - Yadian Technology has invested significantly in R&D, with a total of 146 million yuan over the past three years, and has 133 R&D personnel, accounting for nearly 30% of its total workforce [4] Group 3: IPO Details - The company originally planned to raise 950 million yuan through its IPO, intending to invest in high-end semiconductor equipment industrialization, advanced process semiconductor technology research and development projects, and to supplement working capital [4] - The IPO application was voluntarily withdrawn after failing to progress past the inquiry stage, which began on July 21, 2025 [3][4] Group 4: Market and Regulatory Context - The termination of the IPO reflects the high standards and strict requirements of the Sci-Tech Innovation Board regarding information disclosure quality, technological attributes, and sustainable operational capabilities [6] - Despite being in a strategically supported industry, the company must fully meet regulatory requirements related to board positioning and internal controls [6] - The termination of the project also prompts the lead underwriter, Huatai United Securities, to reassess its risk management and project selection processes [6]
江苏长晶科技股份有限公司启动上市辅导
Jin Rong Jie· 2026-01-15 17:19
据证监会官网显示,江苏长晶科技股份有限公司于2026年1月15日正式启动上市辅导,华泰联合 证券有 限责任公司担任辅导机构。 ...
亚电科技终止科创板IPO 原拟募资9.5亿元
Zhong Guo Jing Ji Wang· 2026-01-15 02:41
中国经济网北京1月15日讯 据上交所官网消息,上交所决定终止江苏亚电科技股份有限公司(以下简称"亚电科技") 首次公开发行股票并在科创板上市审核。 日前,亚电科技和保荐人华泰联合证券有限责任公司向上交所提交了《江苏亚电科技股份有限公司关于撤回首次公开 发行股票并在科创板上市申请文件的申请》和《华泰联合证券关于撤回江苏亚电科技股份有限公司首次公开发行股票 并在科创板上市申请文件的申请》,申请撤回发行上市申请文件。根据《上海证券交易所股票发行上市审核规则》第 六十三条的有关规定,上交所决定终止对亚电科技首次公开发行股票并在科创板上市的审核。 亚电科技系国内领先的湿法清洗设备供应商,主要从事硅基半导体、化合物半导体及光伏领域湿法清洗设备的研发、 生产和销售。 截至招股说明书签署日,钱诚直接持有公司22.59%的股份,通过全资控股的无锡亚腾担任亚电合伙的执行事务合伙 人从而控制亚电合伙所持公司14.89%股份的表决权,通过全资控股的无锡亚腾担任止于至善的执行事务合伙人从而 控制止于至善所持公司3.81%股份的表决权,合计控制公司41.29%股份的表决权,并担任公司董事长兼总经理,系公 司的控股股东、实际控制人。杜建生 ...
容百科技预亏 2019年上市中信证券保荐2募资共25亿
Zhong Guo Jing Ji Wang· 2026-01-14 08:22
中国经济网北京1月14日讯 容百科技(688005.SH)昨晚披露2025年年度业绩预告。经财务部门初步测算, 预计2025年第四季度,实现归属于母公司所有者的净利润约3,000万元,单季度扭亏为盈。预计2025年 年度实现归属于母公司所有者的净利润-19,000万元到-15,000万元,实现归属于母公司所有者扣除非经 常性损益后的净利润-22,000万元到-18,000万元。 公司2024年实现营业收入为1,508,755.47万元;利润总额为42,979.80万元;实现归属于上市公司股东的 净利润为29,591.08万元;实现归属于上市公司股东扣除非经常性损益的净利润为24,407.22万元;实现每 股收益为0.42元。 容百科技发行费用共计9689.71万元,其中中信证券作为保荐机构和主承销商获得承销及保荐费8005万 元。中信证券设立的另类投资子公司中信证券投资有限公司跟投参与容百科技IPO发行战略配售,获配 180万股,获配金额4791.60万元,跟投股份的锁定期为24个月。 公司《2024年半年度募集资金存放与使用情况的专项报告》显示,根据中国证券监督管理委员会《关于 同意宁波容百新能源科技股份有 ...
广康生化及董事长财务总监收警示函 2023上市募7.85亿
Zhong Guo Jing Ji Wang· 2026-01-13 07:32
Core Viewpoint - Guangkang Biochemical received a warning letter from the Guangdong Securities Regulatory Bureau due to violations related to the management and use of raised funds, specifically regarding the purchase of non-principal guaranteed financial products without adequate risk disclosure [1][2]. Group 1: Regulatory Actions - The Guangdong Securities Regulatory Bureau issued a warning letter to Guangkang Biochemical and its executives, Cai Danqun and Chen Haixia, for failing to fulfill their responsibilities under the Information Disclosure Management Measures [2]. - The company was found to have used raised funds to purchase 179 financial products, of which 158 were non-principal guaranteed, without sufficient disclosure of the associated risks in their reports [1][2]. Group 2: Financial Details - Guangkang Biochemical was listed on the Shenzhen Stock Exchange's ChiNext on June 27, 2023, issuing 18.5 million shares at a price of 42.45 yuan per share, which currently trades below its initial offering price [2]. - The total amount raised by the company was 785.325 million yuan, with a net amount of 697.3657 million yuan after deducting issuance costs, which exceeded the initially planned amount by 6.1779 million yuan [2].
股市必读:华融化学(301256)1月9日主力资金净流入1809.28万元
Sou Hu Cai Jing· 2026-01-11 17:44
Core Viewpoint - Huarong Chemical (301256) is actively engaging in financial management and risk mitigation strategies, including providing guarantees for subsidiaries and conducting foreign exchange hedging to manage currency risk. Trading Information Summary - As of January 9, 2026, Huarong Chemical's stock closed at 17.42 yuan, up 2.65%, with a turnover rate of 11.86%, trading volume of 569,300 shares, and a transaction value of 973 million yuan [1] - On the same day, the net inflow of main funds was 18.09 million yuan, while retail investors experienced a net outflow of 1.66 million yuan [1] Company Announcement Summary - The second board meeting of Huarong Chemical on January 8, 2026, approved several proposals, including providing guarantees for subsidiaries, using idle funds for cash management, applying for comprehensive credit from financial institutions, and conducting foreign exchange hedging [1][3] - A temporary shareholders' meeting is scheduled for January 26, 2026, to review the proposals, including the guarantee for subsidiaries and cash management [1] Guarantee for Subsidiaries - Huarong Chemical plans to provide a total guarantee of up to 2.54 billion yuan for its subsidiaries, with 1.25 billion yuan for subsidiaries with a debt-to-asset ratio of 70% or higher, and 1.29 billion yuan for those below that threshold [2][3] - As of December 31, 2025, the actual guarantee amount was 458.67 million yuan, accounting for 26.50% of the latest audited net assets [2] Foreign Exchange Hedging - The company intends to conduct foreign exchange hedging due to increased foreign currency settlement needs, with a maximum contract value of 10 million USD per trading day and a maximum margin and premium of 6.5 million USD [3][6] - The hedging will include products such as forward foreign exchange settlements, foreign exchange swaps, and options, with a focus on USD and EUR [2][3] Cash Management - Huarong Chemical plans to use up to 1.5 billion yuan for cash management, including a maximum of 400 million yuan from idle raised funds, with a rolling usage period of 12 months [5][6] - Investment products will include low-risk options such as structured deposits, notice deposits, and time deposits [5][6]
一律所两律师、一会所两会计师合计被罚没470万!所涉IPO项目已终止审核
梧桐树下V· 2026-01-11 04:18
Core Viewpoint - The China Securities Regulatory Commission (CSRC) has imposed administrative penalties on Jiangsu Shiji Tongren Law Firm and its signing lawyers, as well as on Gongzheng Tianye Accounting Firm and its signing accountants, due to their involvement in the fraudulent IPO process of Suzhou Huadao Biological Pharmaceutical Co., Ltd. [1][5][21] Group 1: Legal Services by Jiangsu Shiji Tongren - Jiangsu Shiji Tongren provided legal services for Huadao Biological's IPO, issuing legal opinions that contained false records [2][12] - The law firm earned a service fee of 754,716.96 yuan (excluding VAT) for its services [2][13] - The firm failed to exercise due diligence during the legal service process, neglecting to verify the authenticity of sales revenue despite clear signs of irregularities [3][15] Group 2: Audit Services by Gongzheng Tianye - Gongzheng Tianye provided audit services for Huadao Biological's IPO, issuing an audit report that also contained false records [5][22] - The agreed audit fee was 2 million yuan, but the firm had not received this amount by the end of the investigation [5][22] - The audit firm did not perform due diligence during the audit process, failing to obtain sufficient and appropriate audit evidence related to revenue authenticity [6][23] Group 3: Penalties Imposed - Jiangsu Shiji Tongren was ordered to rectify its actions, with a confiscation of business income and a fine of 754,716.96 yuan [4][18] - The signing lawyers, Kuan Ying and Cui Yang, received warnings and fines of 200,000 yuan each [4][18] - Gongzheng Tianye was fined 2 million yuan, while the signing accountants, Liu Yong and Yang Yue, received warnings and fines of 400,000 yuan each [6][32]
中金公司(03908)2026年面向专业投资者公开发行永续次级债券(第一期)票面利率为2.38%
智通财经网· 2026-01-08 13:16
智通财经APP讯,中金公司(03908)发布公告,中国国际金融股份有限公司面向专业投资者公开发行不超 过200亿元(含200亿元)永续次级债券已获得中国证券监督管理委员会《关于同意中国国际金融股份有限 公司向专业投资者公开发行永续次级公司债券注册的批复》(证监许可【2025】2290号)。本次债券由华 泰联合证券有限责任公司和兴业证券股份有限公司承销,其中中国国际金融股份有限公司2026年面向专 业投资者公开发行永续次级债券(第一期)(以下简称"本期债券")发行规模为不超过人民币30亿元(含30亿 元)。 2026年1月8日,主承销商在网下向投资者进行了票面利率询价。根据网下投资者询价结果,最终确定本 期债券的票面利率为2.38%。 发行人将按上述票面利率于2026年1月9日至2026年1月12日面向专业机构投资者网下发行。 本期债券票面利率询价区间为1.90%-2.90%。本期债券票面利率将根据网下询价簿记结果,由簿记管理 人按照国家有关规定协商一致在利率询价区间内确定。 ...